Beruflich Dokumente
Kultur Dokumente
India
6 January 2015
Jitendra Sriram*
Equity Strategist and Head of Research, India
HSBC Securities & Capital Markets (India) Private Limited
+91 22 2268 1271
jitendrasriram@hsbc.co.in
abc
Equity Strategy
India
6 January 2015
25
20
15
10
5
0
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
MSCI India
MSCI EM
2. Valuation gap Convergence a year ahead of ROE convergence in 2010; expansion thereafter (12 months forward PE)
25
20
15
10
5
0
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
MSCI India
2006
2007
2008
2009
2010
2011
2012
2013
2014
MSCI EM
3. 12 month forward PB vs. ROE/COE Market potentially factoring COE compression on rate cuts as PB expands (MSCI India)
4.5
2.2
4.0
1.9
3.5
3.0
1.6
2.5
2.0
1.3
1.5
ROE/COE (LHS)
Source: Thomson Reuters Datastream, MSCI, HSBC
Fwd PB (x)
Jul-14
Oct-12
Jan-11
Apr-09
Jul-07
Oct-05
1.0
Jan-04
1.0
abc
Equity Strategy
India
6 January 2015
Tax Burden
Interest Burden
Operating Margins
Asset Turnover
Equity Multiplier
ROE
ROA
Including financials
ROE
ROA
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
0.72
0.94
20.6%
0.80
2.2
24.1%
11.1%
0.74
0.95
19.8%
0.80
2.1
23.9%
11.2%
0.74
0.94
20.5%
0.77
2.1
22.8%
11.0%
0.74
0.92
19.2%
0.81
2.2
23.4%
10.6%
0.73
0.89
14.5%
0.79
2.4
17.9%
7.4%
0.74
0.91
17.8%
0.75
2.3
20.2%
8.9%
0.75
0.90
17.6%
0.74
2.3
19.8%
8.8%
0.73
0.88
15.9%
0.79
2.3
18.4%
8.1%
0.71
0.86
15.4%
0.77
2.3
16.7%
7.2%
0.74
0.85
15.9%
0.71
2.3
16.4%
7.1%
22.3%
4.3%
21.6%
4.1%
21.3%
4.2%
21.3%
4.4%
16.9%
3.3%
18.4%
3.7%
18.0%
3.8%
17.2%
3.6%
15.7%
3.3%
15.1%
3.2%
1.00
Mar-12
Mar-13
Mar-14
Mar-13
Mar-14
Mar-11
Mar-12
Interest Burden
Mar-10
Mar-14
Mar-13
Mar-12
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
Mar-06
Mar-05
0.75
Mar-09
0.80
Mar-08
0.85
Mar-07
0.90
Mar-06
0.95
Mar-05
21%
20%
19%
18%
17%
16%
15%
14%
Operating Margins
25%
0.90
23%
0.80
21%
19%
0.70
17%
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
Mar-06
Mar-14
Mar-13
Mar-12
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
Mar-06
Asset Turnover
Mar-05
15%
0.60
ROE
Source: Prowess, Thomson Reuters Datastream, HSBC
abc
Equity Strategy
India
6 January 2015
Materials
Industrials
Utilities
Financials
Health Care
Consumer Disc
Energy
Telecom
Consumer Staples
IT
Mar-05
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
29%
34%
15%
16%
15%
23%
25%
27%
34%
34%
29%
26%
15%
14%
21%
25%
24%
27%
32%
36%
30%
30%
15%
16%
25%
23%
19%
35%
35%
36%
33%
19%
15%
16%
21%
21%
20%
31%
37%
33%
23%
24%
15%
14%
14%
3%
14%
28%
36%
32%
19%
26%
16%
13%
17%
23%
18%
26%
37%
30%
20%
23%
16%
13%
20%
28%
17%
18%
38%
29%
16%
21%
13%
14%
21%
25%
17%
12%
39%
27%
10%
18%
15%
13%
21%
19%
17%
9%
44%
33%
12%
11%
13%
12%
20%
19%
16%
10%
42%
37%
Mar-14
Mar-14
Mar-12
Mar-13
Materia ls
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
Mar-06
Mar-14
Mar-13
Mar-12
Industria ls
Industrials
50%
30%
45%
27%
40%
24%
30%
21%
25%
18%
IT
Consumer Staples
IT
Mar-12
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
15%
Mar-05
Mar-14
Mar-13
Mar-12
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
Mar-06
Mar-05
20%
Mar-06
35%
1.00
0.95
0.90
0.85
0.80
0.75
0.70
0.65
0.60
Mar-13
Materia ls
Mar-11
Mar-10
Mar-09
Mar-08
Mar-07
Mar-06
Mar-05
40%
35%
30%
25%
20%
15%
10%
5%
0%
Mar-05
Consumer Staples
abc
Equity Strategy
India
6 January 2015
1.5ppt by FY16
Improved macro environment and better policies from the new
India has been one of the best performing markets globally over the past 10 years, with the MSCI India
rising by a factor of three times (or at a 14% CAGR) since 2004, driven largely by strong corporate
earnings and the expansion of valuation multiples. During this period, India has boasted a consistently
higher ROE than other emerging markets and we believe this has justified the 20-30% valuation premium
that the Indian market enjoyed over its peers.
However, corporate Indias ROE fell sharply to 15% in 2014 its lowest level in a decade from a peak
of 22% in 2005. Although ROE has fallen in all major markets over the past few years on weaker global
growth, Indias ROE contraction has been among the most severe. Table 4 on page 3 shows the steep fall
14. India: the best performing major market in the past 10 years (2004-14)
300%
200%
100%
0%
INDIA
CHINA
KOREA
EM
BRAZIL
USA
RUSSIA
WORLD
UK
EUROPE
TAIWAN
JAPAN
abc
Equity Strategy
India
6 January 2015
in ROE has been mainly led by rising interest rates (the interest burden multiplier fell from 0.94 to 0.85
between 2005 and 2014), operating margins down from 20.6% to 15.9% and asset turn deteriorated from
0.80 to 0.71.
ROE compression triggered by multiple factors
In our view, the decline in corporate profitability has been due to three main factors: 1) the rising cost of
resources (spectrum in the telecoms sector, and land in the infrastructure and real estate sectors); 2)
increases in interest rates to temper inflation; and 3) a rising component of overseas revenues.
1. Rising cost of resources: The cost of doing business in India has gone up sharply due to factors such
as an increase in the cost of inputs, difficulty in acquiring land and tougher environmental regulation.
This has been compounded by an increased awareness of the value of resources; the telecoms sector saw a
jump in spectrum charges at auctions; power companies were hurt by Coal India reducing its discount
versus international prices; increases in petroleum prices (prior to the recent fall in crude oil prices) and
subsequently freight rates corrected anomalies in fuel pricing; and ore mining and crude production have
seen an increase in cess and royalty rates.
2. Higher interest rates to temper inflation: RBI hiked rates 13 times between March 2010 and October
2011 as it attempted to curb inflationary pressures. This contributed significantly to the contraction in
ROE, especially among indebted Indian companies. However, lately inflation has fallen sharply, helped
by a decline in the prices of major commodities. Our India economist is expecting RBI to cut its policy
rate by 50bp over the course of 2015, which should help improve corporate profitability (RBI decision:
Promises to cut if inflation stays low, 2 December 2014).
3. An expanding proportion of overseas revenues: Although it is debatable whether overseas
acquisitions reflect poor capital allocation during an era of abundant capital availability (2004-08), the
fact is that returns in developed markets are lower than in India, in line with the lower cost of capital
prevalent in such markets. A number of Indian companies have acquired meaningful overseas assets
(Corus by Tata Steel, Jaguar-Land Rover by Tata Motors, Whyte & Mackay by United Spirits, Taro by
Sun Pharma, Novelis by Hindalco, various African assets by Bharti Airtel, and Repower by Suzlon
Energy to name a few). Most of these overseas investments have struggled to achieve double-digit
returns, whereas domestic Indian operations have generated an average ROE of 15%.
9.0
8.0
30%
7.0
20%
6.0
10%
5.0
0%
Aug-14
Feb-14
Aug-13
Feb-13
Aug-12
Feb-12
Aug-11
Feb-11
Aug-10
Feb-10
4.0
2005
Foreig n Asset as % Total Asset
Foreig n Sales as % Total Revenue
Source: Thomson Reuters Datastream, HSBC
2014
abc
Equity Strategy
India
6 January 2015
Sector drivers
Table 9 shows that the main drag on Indias overall ROE has clearly come from domestic cyclical sectors.
The industrial sectors ROE plunged from 34% in March 2005 to an all-time low of 11% in the last fiscal
year ending March 2014, the materials sectors ROE fell from 29% to 12% between FY05 and FY14;
while the telecoms sector saw ROE drop from 27% to 10%. Other sectors which saw a notable decrease
were financials, utilities and energy. Interestingly, Indian defensive sectors, such as consumer staples, IT
and healthcare, saw an increase in ROE mostly driven by INR depreciation (for healthcare and IT) and
improved rural consumption (for staples).
5%
4%
3%
2%
1%
0%
-1%
-2%
-3%
MSCI INDIA
Industrials
Cons Staples
Financials
Materials S
T/Cm Svs S
Utilities S
Energy S
Health Care
Cons Discr
IT
abc
Equity Strategy
India
6 January 2015
35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
Cons Staples
IT
Cons Discr
Health Care
Financials
MSCI INDIA
Current
Industrials
Energy
Materials
UtilitieS
T/Cm Svs
CY2016e
19. Stocks rated Overweight by HSBC analysts with estimated ROE gains of more than 1ppt between FY14 and FY17e
Company
Ticker
Sector
Rating
Asian Paints
BALLARPUR INDUSTRIES
Bharat Forge
Bharti Airtel
Cadila Healthcare Ltd
Cipla
Coal India Limited
Colgate-Palmolive
Fortis Healthcare
Godrej Consumer Products
Hathway Cable & Datacom
Hindalco
Hindustan Petroleum
ITC
Jubilant Foodworks
Just Dial
Larsen & Toubro
Maruti Suzuki India Ltd
Motherson Sumi
PTC India
Sesa Sterlite
Tata Power
UPL Limited
Voltas Ltd
APNT IN
BILT IN
BHFC IN
BHARTI IN
CDH IN
CIPLA IN
COAL IN
CLGT IN
FORH IN
GCPL IN
HATH IN
HNDL IN
HPCL IN
ITC IN
JUBI IN
JUST IN
LT IN
MSIL IN
MSS IN
PTCIN IN
SSLT IN
TPWR IN
UPLL IN
VOLT IN
Materials
Materials
Consumer Discretionary
Telecommunication Services
Health Care
Health Care
Energy
Consumer Staples
Health Care
Consumer Staples
Consumer Discretionary
Materials
Energy
Consumer Staples
Consumer Discretionary
Information Technology
Industrials
Consumer Discretionary
Consumer Discretionary
Utilities
Materials
Utilities
Materials
Industrials
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight
Overweight (V)
Overweight
Overweight
Overweight
Overweight (V)
Overweight
Overweight
Overweight
Overweight (V)
Overweight (V)
Overweight
Overweight
Overweight
Price
ROE (% FY14)
ROE (% FY17e)
Change (ppt)
760
24
970
481
1645
730
390
2000
152
1125
432
200
696
415
1371
1900
1938
3750
425
120
354
125
352
307
33.1
2.0
16.9
5.0
25.5
13.5
33.3
90.1
3.1
22.0
(12.5)
6.1
7.8
35.3
24.1
25.1
12.8
14.1
34.1
10.4
7.4
2.2
19.2
12.6
35.1
11.0
29.5
11.6
27.3
17.3
35.7
113.2
6.7
24.3
0.5
9.8
11.2
41.7
26.9
34.2
17.5
19.7
39.1
10.9
9.7
9.7
20.5
18.3
2.0
9.0
12.6
6.5
1.9
3.8
2.4
23.1
3.6
2.3
13.0
3.7
3.4
6.4
2.7
9.1
4.8
5.6
5.1
0.6
2.2
7.4
1.3
5.7
Improved macro and potential lower interest rates remains the key catalysts
With a stable new government in place following the general elections, expectations have increased over
a pick-up in growth. In addition, the recent fall in commodity prices and expectations of lower interest
rates are likely to improve profitability among Indian companies. In table 19, we list companies covered
by HSBC fundamental analysts that are rated Overweight (or OW(V)) that have estimated ROE gains of
more than 1ppt between FY14 and FY17e. Interestingly, 16 of the 24 stocks are from cyclical sectors
such as materials, consumer discretionary, energy, industrials and utilities. The ROE expansion will be
led by a fall in interest rates, margin recovery and improved asset turnover ratio (see next page for details
of the DuPont methodology and table 24 for the breakdown of our DuPont analysis by sector).
Equity Strategy
India
6 January 2015
abc
The Indian market is currently trading at 1SD above its long-term average 12-month forward PE and
continues to command a significant premium over its peers in MSCI Asia ex-Japan and MSCI EM. In
2015, we expect the Indian market to move higher, in line with earnings growth albeit with a mild derating in PE. Our end-2015 target for the Sensex is 30,000.
The PE improvement that we saw in 2014, in our view, is partly a reflection of two factors the acceleration
in growth expectations following the formation of a new government with a stable majority and an
improvement in capital efficiency (softer interest rates, better operating leverage, etc). However, with
growth forecasts buoyant over the next two years on the back of an ongoing economic recovery, we see
share prices likely tracking earnings growth, with a small element of PE de-rating (i.e. mean reversion).
The methodology
ROE drivers: DuPont analysis
abc
Equity Strategy
India
6 January 2015
USD strength: In our view, USD strength which is being witnessed could constrain the degree of
easing the markets expect out of the Indian monetary authority. In case the fall in rates is milder than
expected by consensus, some of the tailwinds arising from the interest burden could be muted.
India recovery: Markets are pricing in a recovery in the Indian economy. Any weakness or delay in
the recovery could mean a slower margin recovery than forecast.
Global recovery: Weaker crude oil prices represent stresses for oil exporting nations in their ability
to balance their budget. This could mean a slower global recovery than forecast impacting export
growth for Indian companies. India, however, is a large oil importer; thus weakness in crude oil is
usually positive for the Indian economy.
Taxation: We believe the market is anticipating stable taxation levels. However, there are two
uncertainties. First is the issue of sops extended to few sectors such as autos where rates have been
tempered temporarily. Reversal to prior higher rates could mean higher doses of indirect taxation.
Second is the migration to a goods and services tax (GST) regime in FY16. If rates on GST are
higher than current levels of state imposed sales tax (post set offs for intermediate taxes), this could
again trigger higher indirect taxes, which could mean a higher pricing level for finished goods. Price
elasticity of demand could then come into play, impacting margins.
25
20
15
10
5
0
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
MSCI India
Source: MSCI, Thomson Reuters Datastream, HSBC
Note: Data on calendar year basis
10
MSCI EM
abc
Equity Strategy
India
6 January 2015
target of 30,000
The India market significantly outperformed most emerging markets in 2014. MSCI India outperformed
MSCI EM by 30% and MSCI Asia ex-Japan by 22% in 2014. The strong performance was mostly driven
by a PE rerating and strong 2Q14 earnings performance. With PE valuations now 1SD above the longterm average 12-month forward PE, the India market is now trading at a significant premium to its peers.
An uptick in profitability will lead the market higher from here, in our view.
Relative valuations expensive for financials, industrials and staples
Table 21 shows most India sectors trade at a significant premium to peers. India trades at a 41% premium
to Asia ex-Japan and 52% premium to the global EM index on a 12-month forward PE basis. Comparing
Indian sector valuations with global EM sectors, the financial sector remains the most expensive, trading
at an 87% premium to the global EM financial sector followed by energy, consumer staples and
industrials which are trading at a higher premium to overall country premium. Interestingly, Indian metals
Aggregate Index
Consumer Discretionary
Consumer Staples
Energy
Financials
Health Care
Industrials
Information Technology
Materials
Telecommunication Services
Utilities
Asia
ex-Japan
EM
China
India
Premium to
Asia ex-Japan
Premium to EM
11.2
10.0
20.0
9.3
9.5
22.1
12.7
12.6
11.9
15.1
10.3
10.4
11.4
19.6
5.7
8.6
21.2
13.7
12.7
11.2
13.7
9.3
8.9
9.5
19.8
9.0
6.2
18.7
10.8
21.5
10.1
12.7
11.2
15.9
13.7
32.2
9.6
16.2
23.8
21.9
16.9
11.1
18.0
10.5
41%
36%
61%
4%
71%
8%
72%
33%
-6%
19%
2%
52%
20%
64%
69%
87%
12%
59%
33%
-1%
32%
14%
11
abc
Equity Strategy
India
6 January 2015
is the only sector that is trading at a discount to both Asia ex-Japan and global EM, while all other sectors
are trading a premium.
India remains the preferred market for global investors
Global investors continued to raise exposure to the Indian market through 2014, triggering the rerating.
Indias weight in most regional indices such as EM, Asia ex-Japan and global rose consistently in 2014 to
near a record high.
Looking at absolute foreign institutional investors (FII) equity fund flows into Asia ex-Japan countries,
India continues to receive a disproportionately high share for the second consecutive year. Chart 22
shows that of the six major Asia ex-Japan markets for which FII flows data is available, India has
received more than half since January 2013.
22. Absolute net FIIs fund flows
50
2013
2014
40
30
20
10
0
-10
Taiwan
Korea
Thailand
Indonesia
Philippines
India
Asia ex Japan
1.5%
20%
1.0%
15%
10%
0.5%
5%
0%
Dec-07
12
0.0%
Dec-08
Dec-09
GEM Funds
BRIC Funds
Dec-10
Dec-11
Dec-12
Pacific Funds
Dec-13
Global Funds (RHS)
abc
Equity Strategy
India
6 January 2015
DuPont analysis
24. Breakdown by sector
Materials
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
0.75
0.73
0.74
0.79
0.67
0.74
0.70
0.61
0.74
Interest Burden
0.94
0.94
0.85
0.82
0.85
0.85
0.83
0.77
0.76
Operating Margins
25%
27%
19%
12%
16%
18%
16%
14%
17%
Asset Turnover
0.82
0.71
0.91
1.00
0.81
0.76
0.77
0.67
0.57
Equity Multiplier
2.1
2.3
3.1
3.0
2.5
2.3
2.3
2.3
2.3
29.3%
29.8%
32.7%
23.0%
18.8%
20.3%
16.5%
10.1%
12.2%
Industrials
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-13
Tax Burden
0.75
0.76
0.66
0.68
0.70
0.66
0.66
0.69
0.67
Interest Burden
0.86
0.91
0.86
0.89
0.91
0.90
0.82
0.76
0.64
Operating Margins
12%
16%
14%
17%
20%
19%
20%
19%
17%
Asset Turnover
0.98
0.81
0.71
0.62
0.60
0.58
0.56
0.53
0.47
Equity Multiplier
3.3
3.3
3.5
3.8
3.4
3.4
3.4
3.3
3.4
26.0%
30.2%
19.4%
24.4%
25.8%
22.7%
20.9%
17.8%
11.3%
ROE
ROE
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
Utilities
0.78
0.79
0.72
0.70
0.74
0.74
0.68
0.70
0.70
Interest Burden
0.88
0.85
0.87
0.84
0.82
0.78
0.72
0.71
0.67
Operating Margins
27%
27%
25%
23%
25%
28%
24%
26%
24%
Asset Turnover
0.42
0.44
0.49
0.51
0.49
0.41
0.42
0.40
0.40
Equity Multiplier
1.9
1.9
2.0
2.1
2.2
2.5
2.7
2.8
2.9
14.5%
15.1%
15.4%
14.6%
16.4%
16.2%
13.4%
15.0%
13.1%
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
0.86
0.85
0.88
0.80
0.83
0.88
0.82
0.75
0.77
Interest Burden
0.94
0.95
0.96
0.94
0.98
0.97
0.98
0.98
0.98
Operating Margins
19%
24%
24%
15%
20%
22%
25%
26%
24%
Asset Turnover
0.46
0.76
0.67
0.75
0.72
0.69
0.69
0.73
0.71
Equity Multiplier
2.9
1.7
1.6
1.6
1.5
1.5
1.5
1.5
1.6
20.7%
25.3%
21.1%
13.5%
17.1%
19.5%
21.2%
21.2%
20.2%
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
0.73
0.71
0.72
0.36
0.72
0.81
0.90
0.71
0.74
Interest Burden
0.93
0.91
0.85
0.45
0.78
0.85
0.80
0.78
0.79
Operating Margins
14%
14%
13%
4%
10%
11%
10%
10%
11%
Asset Turnover
1.11
1.07
0.97
0.97
1.08
1.10
1.07
1.04
1.01
Equity Multiplier
2.4
2.5
2.7
4.3
4.0
3.2
3.3
3.3
3.0
24.5%
23.5%
21.1%
2.9%
23.1%
27.8%
25.4%
19.4%
19.5%
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
0.71
0.70
0.71
0.67
0.73
0.72
0.72
0.73
0.73
Interest Burden
0.97
0.96
0.97
0.93
0.95
0.95
0.95
0.95
0.95
Operating Margins
18%
18%
18%
14%
17%
15%
13%
12%
12%
Asset Turnover
0.86
0.79
0.82
0.72
0.73
0.81
0.94
0.96
0.90
Equity Multiplier
2.3
2.1
2.0
2.2
2.1
2.1
2.0
2.0
2.2
24.1%
19.5%
20.4%
14.4%
18.2%
17.2%
17.5%
17.0%
16.4%
ROE
Health Care
ROE
Consumer Disc
ROE
Energy
ROE
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
Telecom
0.88
0.88
0.91
0.95
0.89
0.88
0.82
0.79
0.78
Interest Burden
0.92
0.96
0.97
0.97
0.99
0.93
0.84
0.80
0.88
Operating Margins
22%
27%
28%
25%
30%
25%
20%
18%
19%
Asset Turnover
0.56
0.63
0.61
0.64
0.58
0.48
0.46
0.46
0.45
Equity Multiplier
ROE
2.7
27.4%
2.5
35.3%
2.1
30.9%
1.9
28.0%
1.7
25.7%
1.8
17.5%
1.8
11.6%
1.8
9.4%
1.7
9.9%
13
abc
Equity Strategy
India
6 January 2015
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
0.73
0.74
0.72
0.73
0.70
0.71
0.71
0.71
0.70
Interest Burden
0.99
1.00
0.99
0.99
0.99
0.99
0.99
0.99
1.00
Operating Margins
23%
25%
25%
22%
25%
25%
26%
28%
29%
Asset Turnover
1.07
1.08
1.14
1.25
1.10
1.12
1.17
1.19
1.16
Equity Multiplier
1.8
1.8
1.8
1.8
2.0
1.9
1.8
1.8
1.8
32.3%
35.2%
36.8%
36.2%
37.1%
38.3%
39.3%
44.2%
42.0%
Mar-06
Mar-07
Mar-08
Mar-09
Mar-10
Mar-11
Mar-12
Mar-13
Mar-14
Tax Burden
0.86
0.87
0.84
0.85
0.84
0.83
0.77
0.78
0.78
Interest Burden
1.00
1.00
0.98
0.97
0.97
0.98
0.99
0.99
0.99
Operating Margins
24%
23%
22%
20%
23%
23%
22%
26%
28%
Asset Turnover
1.24
1.22
1.10
1.02
0.92
0.98
0.99
1.09
1.11
Equity Multiplier
1.5
1.5
1.7
1.8
1.7
1.6
1.6
1.5
1.5
36.5%
36.4%
32.8%
31.6%
29.5%
28.8%
26.9%
32.6%
36.7%
ROE
IT
ROE
Source: Prowess, HSBC
14
Equity Strategy
India
6 January 2015
abc
Disclosure appendix
Analyst Certification
The following analyst(s), economist(s), and/or strategist(s) who is(are) primarily responsible for this report, certifies(y) that the
opinion(s) on the subject security(ies) or issuer(s) and/or any other views or forecasts expressed herein accurately reflect their
personal view(s) and that no part of their compensation was, is or will be directly or indirectly related to the specific
recommendation(s) or views contained in this research report: Jitendra Sriram
Important disclosures
Equities: Stock ratings and basis for financial analysis
HSBC believes that investors utilise various disciplines and investment horizons when making investment decisions, which
depend largely on individual circumstances such as the investor's existing holdings, risk tolerance and other considerations.
Given these differences, HSBC has two principal aims in its equity research: 1) to identify long-term investment opportunities
based on particular themes or ideas that may affect the future earnings or cash flows of companies on a 12 month time horizon;
and 2) from time to time to identify short-term investment opportunities that are derived from fundamental, quantitative,
technical or event-driven techniques on a 0-3 month time horizon and which may differ from our long-term investment rating.
HSBC has assigned ratings for its long-term investment opportunities as described below.
This report addresses only the long-term investment opportunities of the companies referred to in the report. As and when
HSBC publishes a short-term trading idea the stocks to which these relate are identified on the website at
www.hsbcnet.com/research. Details of these short-term investment opportunities can be found under the Reports section of this
website.
HSBC believes an investor's decision to buy or sell a stock should depend on individual circumstances such as the investor's
existing holdings and other considerations. Different securities firms use a variety of ratings terms as well as different rating
systems to describe their recommendations. Investors should carefully read the definitions of the ratings used in each research
report. In addition, because research reports contain more complete information concerning the analysts' views, investors
should carefully read the entire research report and should not infer its contents from the rating. In any case, ratings should not
be used or relied on in isolation as investment advice.
HSBC assigns ratings to its stocks in this sector on the following basis:
For each stock we set a required rate of return calculated from the cost of equity for that stocks domestic or, as appropriate,
regional market established by our strategy team. The price target for a stock represents the value the analyst expects the stock
to reach over our performance horizon. The performance horizon is 12 months. For a stock to be classified as Overweight, the
potential return, which equals the percentage difference between the current share price and the target price, including the
forecast dividend yield when indicated, must exceed the required return by at least 5 percentage points over the next 12 months
(or 10 percentage points for a stock classified as Volatile*). For a stock to be classified as Underweight, the stock must be
expected to underperform its required return by at least 5 percentage points over the next 12 months (or 10 percentage points
for a stock classified as Volatile*). Stocks between these bands are classified as Neutral.
Our ratings are re-calibrated against these bands at the time of any 'material change' (initiation of coverage, change of volatility
status or change in price target). Notwithstanding this, and although ratings are subject to ongoing management review,
expected returns will be permitted to move outside the bands as a result of normal share price fluctuations without necessarily
triggering a rating change.
*A stock will be classified as volatile if its historical volatility has exceeded 40%, if the stock has been listed for less than 12
months (unless it is in an industry or sector where volatility is low) or if the analyst expects significant volatility. However,
stocks which we do not consider volatile may in fact also behave in such a way. Historical volatility is defined as the past
15
abc
Equity Strategy
India
6 January 2015
month's average of the daily 365-day moving average volatilities. In order to avoid misleadingly frequent changes in rating,
however, volatility has to move 2.5 percentage points past the 40% benchmark in either direction for a stock's status to change.
37%
Underweight (Sell)
17%
HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments (including derivatives)
of companies covered in HSBC Research on a principal or agency basis.
Analysts, economists, and strategists are paid in part by reference to the profitability of HSBC which includes investment
banking revenues.
Whether, or in what time frame, an update of this analysis will be published is not determined in advance.
For disclosures in respect of any company mentioned in this report, please see the most recently published report on that
company available at www.hsbcnet.com/research.
Additional disclosures
1
2
3
MSCI disclaimer
The MSCI sourced information is the exclusive property of MSCI Inc. (MSCI). Without prior written permission of MSCI, this
information and any other MSCI intellectual property may not be reproduced, redisseminated or used to create any financial
products, including any indices. This information is provided on an as is basis. The user assumes the entire risk of any use
made of this information. MSCI, its affiliates and any third party involved in, or related to, computing or compiling the
information hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a
particular purpose with respect to any of this information. Without limiting any of the foregoing, in no event shall MSCI, any
of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any
damages of any kind. MSCI and the MSCI indexes are services marks of MSCI and its affiliates.
16
Equity Strategy
India
6 January 2015
abc
Disclaimer
* Legal entities as at 30 May 2014
Issuer of report
UAE HSBC Bank Middle East Limited, Dubai; HK The Hongkong and Shanghai Banking Corporation Limited,
HSBC Securities and Capital
Hong Kong; TW HSBC Securities (Taiwan) Corporation Limited; 'CA' HSBC Bank Canada, Toronto; HSBC
Markets (India) Private Limited
Bank, Paris Branch; HSBC France; DE HSBC Trinkaus & Burkhardt AG, Dsseldorf; 000 HSBC Bank (RR),
Registered Office
Moscow; IN HSBC Securities and Capital Markets (India) Private Limited, Mumbai; JP HSBC Securities
52/60 Mahatma Gandhi Road
(Japan) Limited, Tokyo; EG HSBC Securities Egypt SAE, Cairo; CN HSBC Investment Bank Asia Limited,
Beijing Representative Office; The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch; The
Fort, Mumbai 400 001, India
Hongkong and Shanghai Banking Corporation Limited, Seoul Securities Branch; The Hongkong and Shanghai
Telephone: +91 22 2267 4921
Banking Corporation Limited, Seoul Branch; HSBC Securities (South Africa) (Pty) Ltd, Johannesburg; HSBC
Fax: +91 22 2263 1983
Bank plc, London, Madrid, Milan, Stockholm, Tel Aviv; US HSBC Securities (USA) Inc, New York; HSBC
Website: www.research.hsbc.com
Yatirim Menkul Degerler AS, Istanbul; HSBC Mxico, SA, Institucin de Banca Mltiple, Grupo Financiero
CIN: U67120MH1994PTC08157
HSBC; HSBC Bank Brasil SA Banco Mltiplo; HSBC Bank Australia Limited; HSBC Bank Argentina SA; HSBC
Saudi Arabia Limited; The Hongkong and Shanghai Banking Corporation Limited, New Zealand Branch
incorporated in Hong Kong SAR; The Hongkong and Shanghai Banking Corporation Limited, Bangkok Branch
This document has been issued by HSBC Securities and Capital Markets (India) Private Limited ("HSBC") for the information of its customers only. HSBC
Securities and Capital Markets (India) Private Limited is regulated by the Securities and Exchange Board of India. If it is received by a customer of an affiliate of
HSBC, its provision to the recipient is subject to the terms of business in place between the recipient and such affiliate. This document is not and should not be
construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. HSBC has based this document on information obtained from
sources it believes to be reliable but which it has not independently verified; HSBC makes no guarantee, representation or warranty and accepts no responsibility or
liability as to its accuracy or completeness. Expressions of opinion are those of the Research Division of HSBC only and are subject to change without notice. HSBC
and its affiliates and/or their officers, directors and employees may have positions in any securities mentioned in this document (or in any related investment) and
may from time to time add to or dispose of any such securities (or investment). HSBC and its affiliates may act as market maker or have assumed an underwriting
commitment in the securities of companies discussed in this document (or in related investments), may sell them to or buy them from customers on a principal basis
and may also perform or seek to perform investment banking or underwriting services for or relating to those companies and may also be represented in the
supervisory board or any other committee of those companies. The information and opinions contained within the research reports are based upon publicly available
information and rates of taxation applicable at the time of publication which are subject to change from time to time. Past performance is not necessarily a guide to
future performance. The value of any investment or income may go down as well as up and you may not get back the full amount invested. Where an investment is
denominated in a currency other than the local currency of the recipient of the research report, changes in the exchange rates may have an adverse effect on the
value, price or income of that investment. In case of investments for which there is no recognised market it may be difficult for investors to sell their investments or
to obtain reliable information about its value or the extent of the risk to which it is exposed.
HSBC Securities (USA) Inc. accepts responsibility for the content of this research report prepared by its non-US foreign affiliate. All U.S. persons receiving
and/or accessing this report and wishing to effect transactions in any security discussed herein should do so with HSBC Securities (USA) Inc. in the United
States and not with its non-US foreign affiliate, the issuer of this report.
In the UK this report may only be distributed to persons of a kind described in Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005. The protections afforded by the UK regulatory regime are available only to those dealing with a representative of HSBC Bank plc in
the UK. In Singapore, this publication is distributed by The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch for the general
information of institutional investors or other persons specified in Sections 274 and 304 of the Securities and Futures Act (Chapter 289) (SFA) and accredited
investors and other persons in accordance with the conditions specified in Sections 275 and 305 of the SFA. This publication is not a prospectus as defined in
the SFA. It may not be further distributed in whole or in part for any purpose. The Hongkong and Shanghai Banking Corporation Limited Singapore Branch is
regulated by the Monetary Authority of Singapore. Recipients in Singapore should contact a "Hongkong and Shanghai Banking Corporation Limited, Singapore
Branch" representative in respect of any matters arising from, or in connection with this report. In Australia, this publication has been distributed by The
Hongkong and Shanghai Banking Corporation Limited (ABN 65 117 925 970, AFSL 301737) for the general information of its wholesale customers (as
defined in the Corporations Act 2001). Where distributed to retail customers, this research is distributed by HSBC Bank Australia Limited (AFSL No. 232595).
These respective entities make no representations that the products or services mentioned in this document are available to persons in Australia or are
necessarily suitable for any particular person or appropriate in accordance with local law. No consideration has been given to the particular investment
objectives, financial situation or particular needs of any recipient. This publication is distributed in New Zealand by The Hongkong and Shanghai Banking
Corporation Limited, New Zealand Branch incorporated in Hong Kong SAR.
In Japan, this publication has been distributed by HSBC Securities (Japan) Limited. In Hong Kong, this document has been distributed by The Hongkong and
Shanghai Banking Corporation Limited in the conduct of its Hong Kong regulated business for the information of its institutional and professional customers; it
is not intended for and should not be distributed to retail customers in Hong Kong. The Hongkong and Shanghai Banking Corporation Limited makes no
representations that the products or services mentioned in this document are available to persons in Hong Kong or are necessarily suitable for any particular
person or appropriate in accordance with local law. All inquiries by such recipients must be directed to The Hongkong and Shanghai Banking Corporation
Limited. In Korea, this publication is distributed by The Hongkong and Shanghai Banking Corporation Limited, Seoul Securities Branch ("HBAP SLS") for the
general information of professional investors specified in Article 9 of the Financial Investment Services and Capital Markets Act (FSCMA). This publication
is not a prospectus as defined in the FSCMA. It may not be further distributed in whole or in part for any purpose. HBAP SLS is regulated by the Financial
Services Commission and the Financial Supervisory Service of Korea.
In Canada, this document has been distributed by HSBC Bank Canada and/or its affiliates. Where this document contains market updates/overviews, or similar
materials (collectively deemed Commentary in Canada although other affiliate jurisdictions may term Commentary as either macro-research or
research), the Commentary is not an offer to sell, or a solicitation of an offer to sell or subscribe for, any financial product or instrument (including, without
limitation, any currencies, securities, commodities or other financial instruments).
Copyright 2015, HSBC Securities and Capital Markets (India) Private Limited, ALL RIGHTS RESERVED. No part of this publication may be reproduced, stored in a
retrieval system, or transmitted, on any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of
HSBC Securities and Capital Markets (India) Private Limited. MICA (P) 157/06/2014, MICA (P) 171/04/2014 and MICA (P) 077/01/2014
17
abc
Global
Daniel Grosvenor
+44 20 7991 4246
daniel.grosvenor@hsbcib.com
EU and US
Peter Sullivan
Head of Equity Strategy, EU and US
+44 20 7991 6702
peter.sullivan@hsbcib.com
Europe
Robert Parkes
+44 20 7991 6716
robert.parkes@hsbcib.com
John Lomax
Head of Global Emerging Market Equity Strategy
+44 20 7992 3712
john.lomax@hsbcib.com
wietse.nijenhuis@za.hsbc.com
Kishore Muktinutalapati
+91 80 3001 2983
kishoremuktinutalapati@hsbc.co.in
Asia
Herald van der Linde
Deputy Head of Research and Head of Equity Strategy, Asia-Pacific
+852 2996 6575
heraldvanderlinde@hsbc.com.hk
Devendra Joshi
+852 2996 6592
devendrajoshi@hsbc.com.hk
Steven Sun
+852 2822 4298
stevensun@hsbc.com.hk
Roger Xie
+852 2822 4297
rogerpxie@hsbc.com.hk
Taiwan
Jenny Lai
Head of Taiwan Research
+8862 6631 2860
jennylai@hsbc.com.tw
Bruce Warden
+8862 6631 2868
India
Jitendra Sriram
Head of Research, India
+91 22 2268 1271
jitendrasriram@hsbc.co.in
Korea
CEEMEA
Wietse Nijenhuis
+27 11 676 4218
Neel Sinha
Head of Equity Research, South East Asia
+65 6658 0606
neelsinha@hsbc.com.sg
brucebwarden@hsbc.com.tw
Brian Cho
Head of Research, Korea
+822 3706 8750
briancho@kr.hsbc.com
James Jong-pil Lee
+822 3706 8776
jplee@kr.hsbc.com
Latin America
Ben Laidler
LatAm Equity Strategist and Head of Research, Americas
+1 212 5253460
ben.m.laidler@us.hsbc.com
Francisco Schumacher, CFA
Southern Cone & Andean Equity Strategist
+1 212 525 4430
francisco.j.schumacher@us.hsbc.com
Kevin R Gonzalez
Associate
+1 212 525 4394
kevin.r.gonzalez@us.hsbc.com
Andre C Carvalho
Head of Brazil Equity Strategy
+55 11 3371 8190
andre.c.carvalho@hsbc.com.br
Marina F Valle
Equity Strategist
+55 11 3371 8191
marina.f.valle@hsbc.com.br
Gonzalo Fernandez
Mexico Equity Strategist and Head of Equity Research, Mexico
+52 55 5721 3607
go.fernandez@hsbc.com.mx
Jaime Aguilera
Equity Strategist
+52 55 5721 2379
jaime.aguilera@hsbc.com.mx